UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Monitoring of up to 15 years effects of lipoprotein apheresis on lipids, biomarkers of inflammation, and soluble endoglin in familial hypercholesterolemia patients

Orphanet journal of rare diseases, 2021-02, Vol.16 (1), p.110-110, Article 110

2021

Volltextzugriff (PDF)

Soluble endoglin effects on endothelial cells in vitro

Atherosclerosis, 2016-09, Vol.252, p.e156-e156

2016

Volltextzugriff (PDF)

The evaluation of endoglin, vcam-1 and p-selectin expression and co-expression in aortas of apoe-deficient mice – An immunohistochemical study

Atherosclerosis, 2014-08, Vol.235 (2), p.e121-e122

2014

Volltextzugriff (PDF)

Soluble endoglin and markers of endothelial function/dysfunction in mouse aorta – A pilot study

Atherosclerosis, 2014-08, Vol.235 (2), p.e119-e119

2014

Volltextzugriff (PDF)

Cardiotoxicity of chronic sunitinib treatment in normotensive and hypertensive rats

Atherosclerosis, 2014-08, Vol.235 (2), p.e280-e280

2014

Volltextzugriff (PDF)

Atorvastatin-induced endothelial nitric oxide synthase expression in endothelial cells is mediated by endoglin

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2015-06, Vol.66 (3), p.403

2015

Volltextzugriff (PDF)

High levels of soluble endoglin induce inflammation and oxidative stress in aorta compensated with preserved no-dependent vasodilatation mice fed high fat diet

Atherosclerosis, 2016-09, Vol.252, p.e160-e160

2016

Volltextzugriff (PDF)

Effects of atorvastatin treatment on endoglin and enos expression in endothelial cells

Atherosclerosis, 2014-08, Vol.235 (2), p.e124-e124

2014

Volltextzugriff (PDF)

Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death

British journal of cancer, 2009-09, Vol.101 (5), p.792-802

2009

Volltextzugriff (PDF)

Examination of Glucocorticoid Receptor α-Mediated Transcriptional Regulation of P-glycoprotein, CYP3A4 , and CYP2C9 Genes in Placental Trophoblast Cell Lines

Placenta (Eastbourne), 2007-10, Vol.28 (10), p.1004-1011

2007

Volltextzugriff (PDF)

Characterisation of atherogenic effects of low carbohydrate, high protein diet (LCHP) in apoE/LDLR−/− mice

The Journal of nutrition, health & aging, 2015-08, Vol.19 (7), p.710-718

2015

Volltextzugriff (PDF)

The proinflammatory phenotype of type II diabetes mellitus human endothelial cells includes increased endoglin expression and soluble endoglin levels

Atherosclerosis, 2023-08, Vol.379, p.S7

2023

Volltextzugriff (PDF)

Labetalol treatment aggravates estrogen-induced cholestasis

Atherosclerosis, 2021-08, Vol.331, p.e128-e128

2021

Volltextzugriff (PDF)

Labetalol treatment in estrogen-induced cholestasis – A pilot study

Atherosclerosis, 2020-12, Vol.315, p.e154-e154

2020

Volltextzugriff (PDF)

Endoglin is important for monocytes transmigration through endothelial cells during inflammation

Atherosclerosis, 2020-12, Vol.315, p.e113-e113

2020

Volltextzugriff (PDF)

Endoglin blockage is essential in inflammation-induced endothelial dysfunction in human aortic endothelial cells

Atherosclerosis, 2023-08, Vol.379, p.S7

2023

Volltextzugriff (PDF)

Evaluation and selection of antibodies suitable for endoglin detection to be applied in the study of liver and aorta pathology on mice models

Atherosclerosis, 2023-08, Vol.379, p.S6

2023

Volltextzugriff (PDF)

The association of soluble endoglin and endothelial dysfunction in type 2 diabetes mellitus and familial hypercholesterolemia: Impact of statin therapy

Atherosclerosis, 2022-08, Vol.355, p.4

2022

Volltextzugriff (PDF)

Soluble endoglin exacerbates bile acid retention during labetalol treatment in mice with ethinylestradiol-induced cholestasis

Atherosclerosis, 2023-08, Vol.379, p.S61-S62

2023

Volltextzugriff (PDF)

Soluble endoglin is a biomarker of various types of liver damage

Atherosclerosis, 2023-08, Vol.379, p.S42

2023

Volltextzugriff (PDF)

Vascular/Endothelial Dysfunction Is Related To Altered Endoglin Expression And Signaling In Hypercholesterolemic Mice

Atherosclerosis, 2019-08, Vol.287, p.e264-e264

2019

Volltextzugriff (PDF)

Carotuximab effects on endoglin expression and signaling in 7-ketocholesterol induced endothelial dysfunction in HAECs

Atherosclerosis, 2021-08, Vol.331, p.e58-e58

2021

Volltextzugriff (PDF)

Endoglin plays crucial role in the monocyte adhesion and transmigration via endothelial cells

Atherosclerosis, 2020-12, Vol.315, p.e31-e31

2020

Volltextzugriff (PDF)

Effect of treatment with statins on plasma levels of soluble endoglin and endothelial dysfunction in type 2 diabetes mellitus and familial hypercholesterolemia

Atherosclerosis, 2020-12, Vol.315, p.e111-e111

2020

Volltextzugriff (PDF)

Critical impact of endoglin blockage in endothelial dysfunction induced by hypercholesterolemia and hyperglycemia in human aortic endothelial cells

Atherosclerosis, 2022-08, Vol.355, p.8

2022

Volltextzugriff (PDF)

1 – 25 von 121

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99)
Mit Volltextzugriff
(109)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Life Sciences & Biomedicine
(46)
Humans
(28)
Animals
(27)
Biological And Medical Sciences
(26)
Female
(17)
Male
(17)
Medical Sciences
(14)
Fundamental And Applied Biological Sciences. Psychology
(13)
Atherosclerosis
(9)
Cell Biology
(9)
Rabbits
(9)
Adult
(8)
Rats
(8)
Cells, Cultured
(7)
Gene Expression
(7)
Life Sciences
(7)
Mice
(7)
Molecular And Cellular Biology
(7)
Transfection
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Monitoring of up to 15 years effects of lipoprotein apheresis on lipids, biomarkers of inflammation, and soluble endoglin in familial hypercholesterolemia patients

Soluble endoglin effects on endothelial cells in vitro

The evaluation of endoglin, vcam-1 and p-selectin expression and co-expression in aortas of apoe-deficient mice – An immunohistochemical study

Soluble endoglin and markers of endothelial function/dysfunction in mouse aorta – A pilot study

Cardiotoxicity of chronic sunitinib treatment in normotensive and hypertensive rats

Atorvastatin-induced endothelial nitric oxide synthase expression in endothelial cells is mediated by endoglin

High levels of soluble endoglin induce inflammation and oxidative stress in aorta compensated with preserved no-dependent vasodilatation mice fed high fat diet

Effects of atorvastatin treatment on endoglin and enos expression in endothelial cells

Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death

Examination of Glucocorticoid Receptor α-Mediated Transcriptional Regulation of P-glycoprotein, CYP3A4 , and CYP2C9 Genes in Placental Trophoblast Cell Lines

Characterisation of atherogenic effects of low carbohydrate, high protein diet (LCHP) in apoE/LDLR−/− mice

The proinflammatory phenotype of type II diabetes mellitus human endothelial cells includes increased endoglin expression and soluble endoglin levels

Labetalol treatment aggravates estrogen-induced cholestasis

Labetalol treatment in estrogen-induced cholestasis – A pilot study

Endoglin is important for monocytes transmigration through endothelial cells during inflammation

Endoglin blockage is essential in inflammation-induced endothelial dysfunction in human aortic endothelial cells

Evaluation and selection of antibodies suitable for endoglin detection to be applied in the study of liver and aorta pathology on mice models

The association of soluble endoglin and endothelial dysfunction in type 2 diabetes mellitus and familial hypercholesterolemia: Impact of statin therapy

Soluble endoglin exacerbates bile acid retention during labetalol treatment in mice with ethinylestradiol-induced cholestasis

Soluble endoglin is a biomarker of various types of liver damage

Vascular/Endothelial Dysfunction Is Related To Altered Endoglin Expression And Signaling In Hypercholesterolemic Mice

Carotuximab effects on endoglin expression and signaling in 7-ketocholesterol induced endothelial dysfunction in HAECs

Endoglin plays crucial role in the monocyte adhesion and transmigration via endothelial cells

Effect of treatment with statins on plasma levels of soluble endoglin and endothelial dysfunction in type 2 diabetes mellitus and familial hypercholesterolemia

Critical impact of endoglin blockage in endothelial dysfunction induced by hypercholesterolemia and hyperglycemia in human aortic endothelial cells

Suchergebnisse filtern